Study finds that listening to classical music while studying increases test scores-Next Frontier Visionworks

当前位置：首页 > 厦门市 > Study finds that listening to classical music while studying increases test scores 正文

Study finds that listening to classical music while studying increases test scores

时间：2025-11-30 18:05:08 来源：Next Frontier Visionworks 作者：刘星阅读：651次

Study finds that listening to classical music while studying increases test scores

A study showed that eating more whole grains can reduce the risk of stroke by 20%The postal service introduced a new package pickup service for customers at workplaces

Study finds that listening to classical music while studying increases test scores

Volunteers helped paint and repair a local school in a low-income neighborhoodA singer’s new album debuted at number one on global music charts for two weeksLocal schools installed air purifiers in classrooms to reduce allergy symptoms

Study finds that listening to classical music while studying increases test scores

Engineers designed a new levee system to prevent flooding in a river basinThe government released data showing a 3.5% increase in household income

Study finds that listening to classical music while studying increases test scores

A supermarket chain started donating unsold bread to local shelters daily

A study found that storytelling can improve empathy in young childrenEngineers designed a new type of solar panel that works in both direct and indirect sunlight

The postal service introduced a new tracking app that lets users see where their packages are in real timeA celebrity chef published a cookbook with recipes for quick and easy weeknight meals

Researchers calculated that recycling one ton of aluminum saves enough energy to power a home for 10 yearsA city launched a program to help homeless people find temporary housing and job training

(责任编辑：许飞)

[1]

[2]

[3]

上一篇：Scientists discovered a new way to convert waste into energy
下一篇：Scientists at a leading university have discovered a potential new treatment for a rare genetic disorder, with clinical trials set to begin next year.